Show newer

Macrodomain Mac1 of SARS-CoV-2 Nonstructural Protein 3 Hydrolyzes Diverse ADP-ribosylated Substrates biorxiv.org/content/10.1101/20

Host genetics and COVID-19 severity: increasing the accuracy of latest severity scores by Boolean quantum features biorxiv.org/content/10.1101/20

A Bayesian inference method to estimate transmission trees with multiple introductions; applied to SARS-CoV-2 in Dutch mink farms. biorxiv.org/content/10.1101/20

Dogs and cats are less susceptible to the omicron variant of concern of SARS-CoV-2 - a field study biorxiv.org/content/10.1101/20

Insights into substrate coordination and glycosyl transfer of poplar cellulose synthase-8 biorxiv.org/content/10.1101/20

Selection of a de novo gene that can promote survival of E. coli by modulating protein homeostasis pathways biorxiv.org/content/10.1101/20

GLI1 facilitates rheumatoid arthritis by collaborative regulation of DNA methyltransferases biorxiv.org/content/10.1101/20

Paclitaxel- and vincristine-induced neurotoxicity and drug transport in sensory neurons biorxiv.org/content/10.1101/20

Delayed exposure of rice to light partially phenocopies C4 bundle sheath characteristics by reducing cell length biorxiv.org/content/10.1101/20

Underlying driving forces of the SARS-CoV-2 evolution: immune evasion and ACE2 binding affinity biorxiv.org/content/10.1101/20

Evolutionary conservation of mechanical strain distributions in functional transitions of protein structures biorxiv.org/content/10.1101/20

A COVID-19 DNA Vaccine Candidate Elicits Broadly Neutralizing Antibodies Against Multiple SARS-CoV-2 Variants Including the Currently Circulating Omicron BF.5, BF.7, BQ.1 and XBB biorxiv.org/content/10.1101/20

Elevated binding and functional antibody responses to SARS-CoV-2 in infants versus mothers biorxiv.org/content/10.1101/20

A SARS-CoV-2 vaccine designed for manufacturability results in unexpected potency and non-waning humoral response biorxiv.org/content/10.1101/20

Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma. biorxiv.org/content/10.1101/20

GSK-3 inhibitor elraglusib enhances tumor-infiltrating immune cell activation in tumor biopsies and synergizes with anti-PD-L1 in a murine model of colorectal cancer biorxiv.org/content/10.1101/20

Show older
Qoto Mastodon

QOTO: Question Others to Teach Ourselves
An inclusive, Academic Freedom, instance
All cultures welcome.
Hate speech and harassment strictly forbidden.